 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| |
 |
 |
 |
 |
|

In 2002, Celanese advanced its capacity to create even more value and higher profitability
for its stakeholders. Despite the difficult business environment, the year was our company’s
most successful since Celanese became a public company three years ago – from both a strategic
and an operative point of view.
|
|
|
|
|
| |
|
|
|





|
 |
 |

|
|
We continued to pursue our growth objectives even though global economic activity remained
nearly stagnant, markets were characterized by global uncertainty, and consumer confidence
was weak. In 2002, we invested in internal and external growth.
Our acquisition of the European emulsions and global emulsion powders businesses from
Clariant at the end of the year enabled us to extend our acetyls value chain. This
business positions us as a leading producer of emulsions and a supplier to profitable
markets, such as the construction and consumer products industries. This acquisition
represents a further step in our strategy of increasing forward integration. In
addition, the “Estech” joint venture with Hatco, a leading producer of synthetic
lubricants for high-performance engines, for which we produce and sell the base
stocks, neopolyol esters, has enabled us to assume an excellent position in a
market with high growth potential.
In 2002, we commissioned a new plant for ultra-high molecular weight polyethylene (GUR®)
with an annual capacity of 30,000 metric tons, in Bishop, Texas. GUR® is a polymer used
in a variety of applications because of its toughness and abrasion resistance under extreme
mechanical conditions. We are also increasing the annual capacity of our Kelsterbach plant
near Frankfurt to 100,000 metric tons. At this plant, Ticona produces the technical
polymer polyacetal marketed under the brand name Hostaform®.
We have improved our results by controlling our working capital, pursuing a policy of sound
cash management and optimizing our investments. These steps form the basis for
further growth.
|
|
|
|
|
 |
|





|
 |
 |

|
|
We focus on those businesses in which we can expand our market, cost and technology leadership.
We want to grow in these core businesses and in strategic regions. This is why we divested
Trespaphan OPP films to a consortium consisting of Dor-Moplefan and Bain Capital at the end
of the year, and why we sold our allyl amine and U.S. alkyl amine businesses to US Amines Ltd.
|
|
|
|
|
 |
|





|
 |
 |

|
|
Parallel to our growth initiatives, we continued to improve the productivity of our plants and
processes in order to add more value to Celanese.
Two years since it was introduced at Celanese, Six Sigma, a company-wide program to improve
performance and quality, achieved impressive examples of efficiency improvement and has now
become an important feature of our corporate culture. The progress we have made towards
operational excellence has contributed substantially to raising the company’s
profitability.
In 2002, we continued with the implementation of our Focus and Forward initiatives to optimize
our global network of sites, yielding cost reductions of around € 100 million. Our new
synthetic gas plant in Oberhausen, which will supply this important raw material for
the production of chemical intermediates, will also contribute to increasing productivity.
We celebrated the plant’s inauguration on our 75th anniversary of the site at
the end of October.
|
|
|
|
|
 |
|





|
 |
 |

|
|
Celanese will continue to pursue its aim of increasing growth and productivity in 2003. We
will focus on extending our value chain into higher value areas. We have business
relationships in Asia that go back many years, and we want to strengthen our presence
in China. This annual report describes some projects of Celanese Acetate and Ticona
in the Asian region.
Our employees demonstrated tremendous commitment to Celanese in 2002, and they will
continue to be the most important factor behind our success in the future. My
colleagues on the Board and I warmly thank them for their hard work.
Sincerely,

Claudio Sonder
Chairman
|
|
|
|
|
 |
| |
Top |
 |
|
 |